The New Brunswick, N.J.-based drugmaker first announced the split into two independent companies in November 2021. This year, J&J tapped Thibaut Mongon as the consumer health company’s CEO and Larry Merlo, the former president and CEO of CVS, as a chairman.
The name “is inspired by two powerful ideas: ‘ken’ — meaning knowledge, an English word primarily used in Scotland, and ‘vue,’ referencing sight,” according to J&J.
Last year, J&J’s consumer health business — which makes brands including Band-Aid, Tylenol, Neutrogena and Listerine — accumulated $14.6 billion in revenue. Its pharmaceutical division made $52 billion and its medical device side made $27 billion.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
